These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6015086)

  • 1. [First studies on the effect of an anti-5HT(serotonin) substance in pruritus associated with a malignant disease].
    Chiaffitelli C; Suarez Halty L
    An Fac Med Univ Repub Montev Urug; 1966; 51(1):208-11. PubMed ID: 6015086
    [No Abstract]   [Full Text] [Related]  

  • 2. [Do 5HT-3 receptor antagonists ameliorate cholestatic pruritus?].
    Porcel JM; Vives M; Cano M; Rubio-Caballero M
    An Med Interna; 1995 Aug; 12(8):411. PubMed ID: 8924539
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of opioid-induced pruritus with ondansetron: report of four patients.
    Larijani GE; Goldberg ME; Rogers KH
    Pharmacotherapy; 1996; 16(5):958-60. PubMed ID: 8888093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical effect of idarubicin on malignant lymphoma].
    Urabe A; Ohno R; Kuraishi Y; Masaoka T; Ohashi Y; Ogawa M
    Gan To Kagaku Ryoho; 1999 Aug; 26(9):1275-82. PubMed ID: 10478180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary retroperitoneal non-Hodgkin lymphoma presenting with torturous generalized pruritus in an elderly.
    Daponte A; Ioannou M; Gioti C; Kallitsaris A; Dalekos GN; Messinis IE
    Arch Gynecol Obstet; 2007 Apr; 275(4):287-9. PubMed ID: 16947055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipruritic effects of two different 5-HT3 receptor antagonists and an antihistamine in haemodialysis patients.
    Weisshaar E; Dunker N; Röhl FW; Gollnick H
    Exp Dermatol; 2004 May; 13(5):298-304. PubMed ID: 15140020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ondansetron and pruritus in chronic liver disease: a controlled study.
    Jones EA; Molenaar HA; Oosting J
    Hepatogastroenterology; 2007 Jun; 54(76):1196-9. PubMed ID: 17629069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of lymph-node tumours with Vinblastin.
    Eckhardt S
    Ther Hung; 1969; 17(2):57-9. PubMed ID: 5820144
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pruritus in Hodgkin's disease responding to cimetidine].
    Stäubli M; Graf W; Straub PW
    Schweiz Med Wochenschr; 1981 May; 111(20):723-4. PubMed ID: 7256227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degree of fatness after treatment of malignant lymphoma in childhood.
    Nysom K; Holm K; Michaelsen KF; Hertz H; Müller J; Mølgaard C
    Med Pediatr Oncol; 2003 Apr; 40(4):239-43. PubMed ID: 12555252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Etoposide combination chemotherapy for malignant lymphoma: a report of 91 cases].
    Feng F; Zhou L; He X
    Zhonghua Zhong Liu Za Zhi; 1996 May; 18(3):227-9. PubMed ID: 9387262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphoma in three members of the same family.
    Spermolla G; Petrini M; Ambrogi F; Grassi B
    Haematologica; 1981 Apr; 66(2):228-32. PubMed ID: 6792001
    [No Abstract]   [Full Text] [Related]  

  • 13. Malignant lymphoma-associated autoimmune diseases--a descriptive epidemiological study.
    Váróczy L; Gergely L; Zeher M; Szegedi G; Illés A
    Rheumatol Int; 2002 Nov; 22(6):233-7. PubMed ID: 12426661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheumatic manifestations at presentation of Hodgkin's disease and non-Hodgkin's malignant lymphoma. A national survey of one hundred forty-six patients.
    Gaudin P; Rozand Y; Fauconnier J; Phelip X
    Rev Rhum Engl Ed; 1995 May; 62(5):365-75. PubMed ID: 7655870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Menogaril (TUT-7) late phase II study for malignant lymphoma, adult T-cell leukemia and lymphoma (ATLL)].
    Taguchi T; Ohta K; Hotta T; Shirakawa S; Masaoka T; Kimura I
    Gan To Kagaku Ryoho; 1997 Aug; 24(10):1263-71. PubMed ID: 9279345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ifosphamide, etoposide and epirubicin is an effective combined salvage and peripheral blood stem cell mobilisation regimen for transplant-eligible patients with non-Hodgkin lymphoma and Hodgkin disease.
    Bishton MJ; Lush RJ; Byrne JL; Russell NH; Shaw BE; Haynes AP
    Br J Haematol; 2007 Mar; 136(5):752-61. PubMed ID: 17313378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pruritus and fatigue associated with liver disease: is there a role for ondansetron?
    Jones EA
    Expert Opin Pharmacother; 2008 Mar; 9(4):645-51. PubMed ID: 18312165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-associated lymphoma.
    Kaplan LD
    AIDS Clin Rev; 1997-1998; ():349-73. PubMed ID: 9305455
    [No Abstract]   [Full Text] [Related]  

  • 19. Anterior mediastinal masses after cancer therapy: recurrences or benign lesions?
    Abdulnour E; Beauregard P
    Can J Surg; 1993 Dec; 36(6):504, 536. PubMed ID: 8258127
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ondansetron for cholestatic pruritus].
    Lamelo Alfonsín F; Vila Arias M; San Martín Moreira J; Silva César M
    An Med Interna; 1998 Aug; 15(8):456. PubMed ID: 9780438
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.